This study reviews the 2022 EANO guidelines for diffuse gliomas, outlining updated diagnostic and therapeutic protocols. It emphasizes the integration of molecular diagnostics and personalized treatment strategies, enhancing patient outcomes in adult neuro-oncology through evidence-based recommendations.